S. Romito

Phase III Randomized Trial of FOLFIRI Versus FOLFOX4 in the Treatment of Advanced Colorectal Cancer: A Multicenter Study of the Gruppo Oncologico Dell’Italia Meridionale

Giuseppe Colucci, Vittorio Gebbia, G Paoletti et al. · Journal of Clinical Oncology · 2005 · 781 citations

Medicine, Oncology, Pharmacotherapy +11

Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial

Nicola Normanno, Anna Maria Rachiglio, Matilde Lambiase et al. · Annals of Oncology · 2015 · 146 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study)

Ferdinando De Vita, Francesco Giuliani, Michele Orditura et al. · Annals of Oncology · 2007 · 102 citations · Full text

Medicine, Oncology, Pharmacology +6

Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): a randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX

Fortunato Ciardiello, Nicola Normanno, Erika Martinelli et al. · Annals of Oncology · 2016 · 98 citations

Medicine, Oncology, Pharmacotherapy +11

FOLFIRI with or without celecoxib in advanced colorectal cancer: a randomized phase II study of the Gruppo Oncologico dell'Italia Meridionale (GOIM)

Evaristo Maiello, Francesco Giuliani, Vittorio Gebbia et al. · Annals of Oncology · 2006 · 33 citations · Full text

Medicine, Oncology, Pharmacology +7